课题基金 / 基金详情

Expression & localization of IGF system in human relapsed prostatic carcinoma

Expression & localization of IGF system in human relapsed prostatic carcinoma
IGF系统在人复发性前列腺癌中的表达和定位
批准号:
11671558
负责人:
USUI Tsuguru
金额:
$2.05万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
1999
资助国家:
日本
项目状态:
已结题
起止时间:
1999 至 2000

项目摘要

项目成果

USUI Tsuguru的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The insulin-like growth factor (IGF) system, which is composed of two ligands (IGF- I, IGF- II), two receptors (IGFR- I, IGFR- II) and six binding proteins (IGFBP- 1 to - 6), plays an important role in cell biology. The mRNA expression of the IGF system in human prostate cancer tissue was examined. Expression of the IGF system, except IGFBP- 1, was detected in all prostate cancer tissue samples. The expression of IGF- II and IGFBP- 2 significantly correlated with pathologic stage, lymph node metastasis, histologic differentiation and PSA levels after hormone therapy. However, expression of IGF- I significantly lower in advanced patients. In conclusion, in the IGF system, IGF- II and IGFBP- 2 play a role in human prostate cancer progression and their increased expression is a possible candidate for a prognostic indicator in hormone-treated prostate cancer patients.IGFBP- 7 mRNA, which include in IGFBP superfamily, were expressed in the human BPH derived epithelial and stromal cells by RT-PCR method. However, the expression of IGFBP- 7 mRNA was not detected in human prostate cancer cell line. The results of Northern blot analysis showed the absence of expression in prostate cancer tissues. The inhibitory activity of IGFBP- 7 on cell growth rate might be applicable for the treatment of patients with prostate cancer.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
Mutaguchi K, Yasumoto H, Matsubara A, Nakamoto T, Usui T: "Study of IGFBP-7 in human prostate."Clinical Endocrinology. 48(Supp). 154-156 (2000)
Mutaguchi K、Yasumoto H、Matsubara A、Nakamoto T、Usui T:“人类前列腺中 IGFBP-7 的研究”。临床内分泌学。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
亭島淳,安本博晃,神谷研二,碓井亜 他: "マウス肝癌におけるIGFBP-7遺伝子の発現低下"ホルモンと臨床,. 48・増刊. 149-153 (2000)
Jun Teijima、Hiroaki Yasumoto、Kenji Kamiya、A Usui 等人:“小鼠肝癌中 IGFBP-7 基因的表达降低”《激素与临床科学》,48,特刊(2000 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
松原昭郎,中本貴久,碓井亜: "前立腺癌の診断と治療最新の研究動向"日本臨床. 58・増刊. 157-162 (2000)
Akio Matsubara、Takahisa Nakamoto、Akira Usui:“前列腺癌诊断和治疗的最新研究趋势”,日本临床实践 58/特刊(2000 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
牟田口和昭,安本博晃,松原昭郎,中本貴久,碓井亜: "ヒト前立腺組織におけるIGFBP-7の検討"ホルモンと臨床. 48・増刊. 154-156 (2000)
Kazuaki Mutaguchi、Hiroaki Yasumoto、Akio Matsubara、Takahisa Nakamoto、A Usui:“人类前列腺组织中 IGFBP-7 的检查”激素和临床研究 48,特别版(2000 年)。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
8
    Clinical application and functional analysis of the cofactor of androgen receptor in prostate cancer
    • 批准号:
      18591755
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.48万
    • 财政年份:
      2006
    • 负责人:
      USUI Tsuguru
    • 依托单位:
    Development of new therapy for hormone independent prostate cancer.
    • 批准号:
      15591689
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.11万
    • 财政年份:
      2003
    • 负责人:
      USUI Tsuguru
    • 依托单位:
    Experimental chemotherapy and radiotherapy for metastatic mouse bladder cancer
    • 批准号:
      03670754
    • 项目类别:
      Grant-in-Aid for General Scientific Research (C)
    • 资助金额:
      $1.34万
    • 财政年份:
      1991
    • 负责人:
      USUI Tsuguru
    • 依托单位:
    国内基金
    海外基金
    基于铁死亡探讨IGF-BP-3在血管钙化中的作用及机制研究
    • 批准号:
      JCZRLH202600166
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    黄精来源的外泌体靶向IGF2R调控巨噬细胞胞葬功能影响骨关节炎进展的作用机制研究
    KAT6A介导IGF2BP2乙酰化在宫颈癌ICI治疗抵抗中的机制研究
    • 批准号:
      JCZRLH202600764
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
    • 依托单位:
    OTUB1稳定m6A结合蛋白IGF2BP1参与心肌缺血再灌注损伤的机制研究
    • 批准号:
      2026JJ81329
    • 项目类别:
      省市级项目
    • 资助金额:
      --
    • 批准年份:
      2026
    • 负责人:
      刘继佳
    • 依托单位: